OCULAR THERAPEUTIX, INC Depreciation
OCULAR THERAPEUTIX, INC (OCUL) reported Depreciation of $383.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2014-11-12
- OCULAR THERAPEUTIX, INC depreciation for the quarter ending 2014-09-30 was $139.00K, a 51.09% increase year-over-year.
- OCULAR THERAPEUTIX, INC depreciation for the quarter ending 2013-09-30 was $92.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month |
|---|---|---|---|
| 2014-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $383.00K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $244.00K 10-Q · filed 2014-08-29 | ||
| 2013-09-30 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $279.00K 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $187.00K 10-Q · filed 2014-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |